Clinical Trial Update: Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer [Phase 2]

View source ↗

Summary

Clinical Trial Update describes a Phase 2 study evaluating a therapy adapted for high-risk and low-risk HIV-associated anal cancer, with the trial currently act…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aids-related Anal Carcinoma
• Anal Margin Squamous Cell Carcinoma
• Anal Squamous Cell Carcinoma
• HIV Infection
• Rectal Cancer
• Rectal Squamous Cell Carcinoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: AIDS-Related Anal Carcinoma, Anal Margin Squamous Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING